| Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals. | |
| | |
MedLine Citation:
|
PMID: 23098889 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Diagnostic karyotype and molecular studies represent the most powerful prognostic indicators in acute myeloid leukemia and provide the framework for risk stratification. Risk stratification in ALL has also a vital role in predicting outcome and identifying patients at higher risk of relapse with multiagent chemotherapy, but the role of diagnostic karyotype and molecular markers in adult ALL is limited to few well recognized cytogenetic abnormalities. PATIENTS AND METHODS: We report a case series of 6 adult ALL patients with a characteristic molecular abnormality that have done poorly with chemotherapy. Between April 2004 and November 2009, 72 adult ALL patients (Pre-B-cell 61; T-cell 11) were referred to and treated at the Leukemia/BMT Program of BC in Vancouver, Canada. FISH for BCR-ABL fusion was positive in 12 of 61 Pre-B cell ALL patients. An additional 6 patients were negative for this typical fusion but had FISH abnormalities related to BCR and/or ABL1. RESULTS: In this report, we describe the clinical and hematopathologic characteristics of these 6 patients and their poor outcome. We review the literature where only 2 similar cases with normal karyotype Pre-B ALL and associated FISH BCR/ABL1 numerical abnormalities were found. CONCLUSION: We recommend screening all adult pre-B ALL patients with normal karyotype for this clonal abnormality and suggest classifying these ALL patients into the high-risk category. |
| | |
Authors:
|
Yasser R Abou Mourad; Rahul Bhargava; Hélène Bruyère; Tanya Gillian; Michael J Barnett; Donna L Forrest; Thomas J Nevill; Cynthia L Toze; Stephen H Nantel; John D Shepherd |
Related Documents
:
|
23413629 - Prevalence of periodontal pathogens and metabolic control of type 1 diabetes patients. 23561509 - Different patterns of gray matter atrophy in early- and late-onset alzheimer's disease. 23260259 - Diagnostic capability of lamina cribrosa thickness by enhanced depth imaging and factor... 23077459 - Cathepsin x in serum from patients with colorectal cancer: relation to prognosis. 22938819 - Epilepsy, poverty and early under-nutrition in rural ethiopia. 23424599 - Detection and analysis of autoantigens targeted by autoantibodies in immunorelated panc... 1082649 - Urgent fibre-optic panendoscopy in upper gastro-intestinal haemorrhage. 19673169 - Specific ige against alternaria alternata in atopic dermatitis and asthma patients. 6338209 - Diagnostic procedures using the patient's existing dentures. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-23 |
Journal Detail:
|
Title: Clinical lymphoma, myeloma & leukemia Volume: - ISSN: 2152-2669 ISO Abbreviation: Clin Lymphoma Myeloma Leuk Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101525386 Medline TA: Clin Lymphoma Myeloma Leuk Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Crown Copyright © 2012. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Leukemia/BMT Program of BC, British Columbia Cancer Agency, Vancouver General Hospital and University of British Columbia, British Columbia, Canada. Electronic address: ymourad@bccancer.bc.ca. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Safety and Efficacy of Triplet Regimens in Newly Diagnosed Light Chain Amyloidosis.
Next Document: HIV Non-B Subtype Distribution: Emerging Trends and Risk Factors for Imported and Local Infections N...